Literature DB >> 22437476

Impaired gastric emptying and small bowel transit in children with mitochondrial disorders.

Jatinder Bhardwaj1, David Q Wan, Mary Kay Koenig, Yuying Liu, Syed Shahrukh Hashmi, Jon Marc Rhoads.   

Abstract

OBJECTIVES: The primary aim of our study was to evaluate gastric emptying (GE) and intestinal transit time (ITT) in children with mitochondrial disorders (MD), and secondarily to evaluate the effect of prokinetics in those with prolonged GE.
METHODS: We enrolled subjects 3 to 18 years with MD and having any of the following gastrointestinal (GI) symptoms: abdominal pain, vomiting, constipation, diarrhea, or gastroesophageal reflux. Abdominal pain was scored by visual analog pain scale (1-10). Age-appropriate diet was labeled with radioactive technetium-99 sulfur colloid and its movement tracked along the GI tract. Delayed GE based on our institutional standards was defined as half emptying time >90 minutes for a solid and >60 minutes for a semisolid meal. Prolonged ITT was defined as >4 hours for the tracer to pass from mouth to cecum. A prokinetic was instituted to those with delayed GE, and the study was repeated if possible in 4 to 8 weeks.
RESULTS: Of the 26 subjects, 18 (69%) had delayed GE (median GE 99 minutes) and 12 (46%) had prolonged ITT. The study was repeated in 9 subjects after administering a prokinetic for >1 month. GE normalized in only 3 subjects (median GE on treatment 128 minutes). Mean abdominal pain score, which was 4.8 (max 10) in the 9 subjects, did not improve (5.6 after prokinetic therapy).
CONCLUSIONS: A high prevalence of delayed GE and prolonged ITT was seen in children with MD having GI symptoms, and these abnormalities were poorly responsive to prokinetic therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22437476     DOI: 10.1097/MPG.0b013e3182514805

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

Review 1.  Carnitine Palmitoyl Transferase Deficiency in a University Immunology Practice.

Authors:  Kiley Bax; Paul J Isackson; Molly Moore; Julian L Ambrus
Journal:  Curr Rheumatol Rep       Date:  2020-02-14       Impact factor: 4.592

Review 2.  Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature.

Authors:  Emma M Tillman; Keaton S Smetana; Likeselam Bantu; Merrion G Buckley
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Mar-Apr

3.  Gastrointestinal dysfunction in autism spectrum disorder: the role of the mitochondria and the enteric microbiome.

Authors:  Richard E Frye; Shannon Rose; John Slattery; Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-07

4.  Sleep disordered breathing in children with mitochondrial disease.

Authors:  Ricardo A Mosquera; Mary Kay Koenig; Rahmat B Adejumo; Justyna Chevallier; S Shahrukh Hashmi; Sarah E Mitchell; Susan E Pacheco; Cindy Jon
Journal:  Pulm Med       Date:  2014-12-23

Review 5.  Gastrointestinal manifestations of mitochondrial disorders: a systematic review.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Therap Adv Gastroenterol       Date:  2016-10-06       Impact factor: 4.409

6.  Gastroesophageal Reflux in Neurologically Impaired Children: What Are the Risk Factors?

Authors:  Seung Kim; Hong Koh; Joon Soo Lee
Journal:  Gut Liver       Date:  2017-03-15       Impact factor: 4.519

7.  Surfactant protein A reduces TLR4 and inflammatory cytokine mRNA levels in neonatal mouse ileum.

Authors:  Lidan Liu; Chaim Z Aron; Cullen M Grable; Adrian Robles; Xiangli Liu; Yuying Liu; Nicole Y Fatheree; J Marc Rhoads; Joseph L Alcorn
Journal:  Sci Rep       Date:  2021-01-28       Impact factor: 4.379

8.  Mitochondrial dysfunction in the gastrointestinal mucosa of children with autism: A blinded case-control study.

Authors:  Shannon Rose; Sirish C Bennuri; Katherine F Murray; Timothy Buie; Harland Winter; Richard Eugene Frye
Journal:  PLoS One       Date:  2017-10-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.